Why We Die: The New Science of Aging and the Quest for Immortality

Added:

Biodemographic Limits and the Evolutionary Inevitability of Aging

In contrast to the optimistic pursuit of radical life extension and immortality, biodemographers like S. Jay Olshansky and evolutionary biologists argue that human lifespan has a firm biological ceiling. This perspective posits that aging is not a programmed disease to be cured, but an evolutionary byproduct. Because natural selection prioritizes reproduction over post-reproductive survival, biological systems are not built for indefinite maintenance. Proponents of this view argue that cellular and molecular decay is too systemic to fully reverse, making true immortality a biological impossibility. Instead of chasing unrealistic lifespan extension, they advocate for focusing resources on 'compression of morbidity'—maximizing healthspan so that people remain healthy until a natural, biologically determined limit. They warn that focusing on extreme longevity risks diverting critical resources from public health and could exacerbate global socioeconomic inequalities.

Basic cell biology concepts, particularly cellular senescence (the process by which cells permanently stop dividing) and programmed cell death (apoptosis).
The structure and function of DNA, including how telomeres protect the ends of chromosomes and the role of the telomerase enzyme.
Fundamental genetic processes of DNA damage, oxidative stress, and the critical role of protein synthesis and folding (ribosome function).
Key evolutionary theories of aging, such as Thomas Kirkwood's 'disposable soma' theory and Peter Medawar's mutation accumulation hypothesis.
Emerging biogerontology interventions, such as senolytic drugs designed to clear senescent cells and NAD+ restoration therapies.
The science of cellular reprogramming, including Yamanaka factors, and how researchers are attempting to reset cell age.
The societal, economic, and ethical implications of radical life extension, including resource distribution, generational equity, and demographic shifts.
Epigenetics and biomarkers of aging, specifically how 'epigenetic clocks' (such as Horvath's clock) are used to measure biological age.
117.1K views2.3Klikes1:02:30@harvardsciencebooktalksand4527Original Release: 2024-05-31

Aging results from the accumulation of molecular damage over time, with no inherent biological program for death; instead, evolution has shaped lifespan based on survival trade-offs, where larger animals and those with better survival strategies (like flying bats) tend to live longer. While breakthroughs in understanding aging mechanisms—such as caloric restriction mimetics, senolytic drugs targeting harmful senescent cells, and cellular reprogramming techniques—are advancing rapidly, achieving true immortality faces significant challenges including the brain's limited regenerative capacity and the complexity of coordinating systemic repairs across all body tissues simultaneously. The theoretical possibility exists, but realizing it requires overcoming formidable scientific, ethical, and philosophical obstacles.